YOLFTbeta
MA

Mark Dynamics Indonesia Tbk PT

MARK · JK · Healthcare / Medical Instruments & Supplies

960.00IDR-10.00 (-1.03%)

Price History

Full chart

Market Stats

Previous Close970.00
Open965.00
Day Range935.00 – 965.00
52-Week Range546.28 – 1,265.00
Volume4.25M
Market Cap4.39T
P/E (TTM)13.04
Forward P/E0.00
EPS88.59
Dividend Yield7.79%
Beta0.24
50-Day Avg1,098.80
200-Day Avg904.05

About

PT Mark Dynamics Indonesia Tbk manufactures and sells porcelain former products in Indonesia and internationally. The company offers hand formers for nitrile gloves. Its products used for examination, industrial, medical, household, and custom-made applications. The company was founded in 2002 and is headquartered in Deli Serdang, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Ridwan Goh
  • Employees656
  • HeadquartersJI. Pelita Barat No. 2, Deli Serdang, Indonesia, 20362, Indonesia
  • Websitehttps://www.markdynamicsindo.com

Leadership

  • Mr. Ridwan GohCEO & President Director · b. 1983
  • Budi MuharsyahHead of Financial Department
  • Mr. Kun Jian ChowDirector & Senior Head of Marketing · b. 1995
  • Mr. Naomi Elisabeth LumbantobingHuman Resource Manager · b. 1987
  • Ms. . RianaDirector & Head of Internal Audit Unit · b. 1979
  • Ms. Yuriani TrisjoyoCompany Secretary · b. 1994

Financials

Income Statement

Currency: IDR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue153.48B194.64B207.22B239.79B325.47B361.54B565.44B1.19T823.66B559.47B909.99B837.31B
Growth (%)-+26.82%+6.47%+15.71%+35.73%+11.08%+56.40%+111.08%-30.99%-32.07%+62.65%-7.99%
Cost of Revenue127.20B161.35B159.66B149.52B180.36B205.12B328.64B614.38B421.08B295.77B468.33B425.91B
Gross Profit26.28B33.29B47.56B90.26B145.11B156.42B236.79B579.12B402.57B263.70B441.65B411.41B
Gross Margin17.12%17.10%22.95%37.64%44.59%43.27%41.88%48.52%48.88%47.13%48.53%49.13%
Operating Expense15.73B18.13B16.65B22.55B32.93B34.09B53.25B64.07B77.80B72.30B88.20B61.09B
Operating Income10.55B15.16B30.92B67.72B112.18B122.33B183.54B515.05B324.77B191.40B353.46B350.31B
Operating Margin6.87%7.79%14.92%28.24%34.47%33.84%32.46%43.15%39.43%34.21%38.84%41.84%
EBITDA10.85B16.48B36.68B68.51B122.97B132.71B211.15B533.61B344.17B234.36B399.83B380.97B
EBITDA Margin7.07%8.46%17.70%28.57%37.78%36.71%37.34%44.71%41.79%41.89%43.94%45.50%
Net Income5.35B10.40B19.59B47.06B81.91B88.00B144.03B392.15B243.09B156.02B286.54B283.88B
Net Income Margin3.49%5.35%9.45%19.62%25.17%24.34%25.47%32.86%29.51%27.89%31.49%33.90%
R&D453.29M257.58M451.48M642.41M667.51M270.98M264.50M-----
R&D as % of Total Revenue0.30%0.13%0.22%0.27%0.21%0.07%0.05%-----
Interest Expense1.33B1.11B1.66B2.10B3.07B4.38B5.91B6.85B4.59B3.70B2.28B2.06B
Interest Expense % of Total Revenue0.87%0.57%0.80%0.87%0.94%1.21%1.05%0.57%0.56%0.66%0.25%0.25%

Balance Sheet

Currency: IDR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets129.19B143.66B170.94B227.60B318.08B441.25B719.73B1.08T1.01T951.55B955.84B1.02T
Total Liabilities77.53B84.30B90.32B60.76B80.34B142.23B310.25B334.82B161.59B111.45B94.94B120.12B
Total Equity51.66B59.36B80.62B166.84B237.74B299.02B406.71B740.88B841.02B837.32B858.07B899.77B
Cash6.47B14.83B4.88B17.94B5.43B27.98B39.66B104.22B51.26B54.92B75.73B90.27B
Total Debt967.28M484.52M118.19M26.38B44.59B114.06B162.05B134.24B121.45B57.36B31.01B65.96B
Net Debt-5.50B-14.35B-4.76B8.44B39.16B86.08B122.38B30.02B70.19B2.44B-44.72B-24.32B

Cash Flow

Currency: IDR2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow46.51B-719.82M-35.52B46.14B50.92B44.43B214.59B325.40B252.07B234.32B340.63B245.56B
Investing Cash Flow-27.65B-7.51B-21.12B-23.47B-70.24B-64.76B-152.15B-175.53B-43.81B-11.31B-25.76B35.25M
Financing Cash Flow-22.52B16.60B46.69B-9.61B6.81B42.87B-55.09B-91.62B-214.60B-219.35B-294.06B-231.05B
Capital Expenditure27.65B7.51B21.12B23.49B70.24B64.76B162.14B179.29B43.81B16.80B9.34B21.17B
Free Cash Flow18.86B-8.23B-56.64B22.65B-19.32B-20.32B52.45B146.11B208.26B217.52B331.29B224.38B
Dividends Paid-11.40B11.40B11.40B11.40B26.60B26.60B57.00B190.00B152.00B266.00B266.00B
FCF to OCF40.54%1143.27%159.47%49.09%-37.95%-45.73%24.44%44.90%82.62%92.83%97.26%91.38%
Dividend Paid to FCF--138.53%-20.13%50.33%-59.00%-130.90%50.72%39.01%91.23%69.88%80.29%118.55%

Earnings

Report DateSep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023
EPS Estimate-----------------------
EPS Actual4.333.904.754.866.076.075.815.365.926.157.4610.0714.2318.2422.6031.8230.5332.9221.053.296.718.038.94
Surprise-----------------------
Timing-----------------------

Key Statistics & Ratios

Market Cap4.39T
Enterprise Value4.29T
Trailing P/E13.04
Forward P/E0.00
Price / Sales4.27
Price / Book4.86
EPS88.59
Book Value234.67
Revenue (TTM)1.03T
Gross Profit (TTM)485.25B
EBITDA438.88B
Profit Margin32.71%
Operating Margin36.09%
Return on Equity37.98%
Return on Assets25.27%
Shares Outstanding3.80B
Shares Float749.82M
Beta0.24
Dividend Yield7.79%
Dividend Rate90.00
Payout Ratio101.64%

Dividends

20263×
20.00Nov 13, 202620.00Aug 14, 202650.00May 20, 2026
20253×
20.00Nov 6, 202520.00Aug 11, 202530.00May 27, 2025
20243×
20.00Nov 14, 202420.00Aug 16, 202430.00May 28, 2024
20232×
5.00Oct 31, 202335.00Jun 12, 2023
20221×
50.00Jun 9, 2022
20211×
15.00Jun 9, 2021
20201×
7.00Aug 25, 2020
20191×
7.00May 23, 2019
20181×
3.00May 9, 2018

Stock Splits

  • Feb 11, 20195:1